Russia Develops Anti-Aging Gene Therapy Aimed at Extending Human Lifespan to 150 Years

Russia is moving ahead with a groundbreaking scientific effort to develop what could become the world’s first anti-aging gene therapy. The experimental treatment focuses on blocking the RAGE gene, which is believed to play a crucial role in the aging process at the cellular level.

According to Russia’s Science and Higher Education Minister Denis Sekirinsky, researchers are working on a drug that could slow down—or even stop—cellular deterioration. If successful, this therapy may significantly extend human lifespan and improve overall health in old age.

The project has gained strong political support from President Vladimir Putin, who previously stated that humans could potentially live up to 150 years. His remarks came during an AI summit last November, highlighting Russia’s growing interest in longevity science.

The anti-aging initiative is part of a broader national mission, with a target to save around 175,000 lives by 2030. Scientists have reportedly been instructed to fast-track their research, underlining the urgency and importance of the project.

While the development marks a major step forward in medical science, experts caution that such treatments will require rigorous testing to ensure safety, effectiveness, and long-term impact before becoming available for public use.

Disclaimer: The information provided in this article is for general informational purposes only. While we endeavor to keep the information up to date and correct, News Setu makes no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability of the content. Any reliance you place on such information is strictly at your own risk.